Back

An Allele of the MTHFR one-carbon metabolism gene predicts severity of COVID-19

Petrova, B.; Syphurs, C.; Culhane, A. J.; Chen, J.; Chen, E.; Cotsapas, C.; Esserman, D.; Montgomery, R.; Kleinstein, S.; Smolen, K.; Mendez, K.; Lasky-Su, J.; Steen, H.; Levy, O.; Diray-Arce, J.; Kanarek, N.

2025-03-03 infectious diseases
10.1101/2025.02.28.25323089 medRxiv
Show abstract

While the public health burden of SARS-CoV-2 infection has lessened due to natural and vaccine-acquired immunity, the emergence of less virulent variants, and antiviral medications, COVID-19 continues to take a significant toll. There are > 10,000 new hospitalizations per week in the U.S., many of whom develop post-acute sequelae of SARS-CoV-2 (PASC), or "long COVID", with long-term health issues and compromised quality of life. Early identification of individuals at high risk of severe COVID-19 is key for monitoring and supporting respiratory status and improving outcomes. Therefore, precision tools for early detection of patients at high risk of severe disease can reduce morbidity and mortality. Here we report an untargeted and longitudinal metabolomic study of plasma derived from adult patients with COVID-19. One-carbon metabolism, a pathway previously shown as critical for viral propagation and disease progression, and a potential target for COVID-19 treatment, scored strongly as differentially abundant in patients with severe COVID-19. A follow-up targeted metabolite profiling revealed that one arm of the one-carbon metabolism pathway, the methionine cycle, is a major driver of the metabolic profile associated with disease severity. The methionine cycle produces S-adenosylmethionine (SAM), the methyl group donor important for methylation of DNA, RNA, and proteins, and its high abundance was reported to correlate with disease severity. Further, genomic data from the profiled patients revealed a genetic contributor to methionine metabolism and identified the C677T allele of the MTHFR gene as a pre-existing predictor of disease trajectory - patients homozygous for the MTHFR C677T have higher incidence of experiencing severe disease. Our results raise the possibility that screening for the common genetic MTHFR variant may be an actionable approach to stratify risk of COVID severity and may inform novel precision COVID-19 treatment strategies.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 10%
14.5%
2
Cell
370 papers in training set
Top 2%
8.3%
3
Med
38 papers in training set
Top 0.1%
7.0%
4
Cell Reports Medicine
140 papers in training set
Top 0.5%
6.2%
5
Gastroenterology
40 papers in training set
Top 0.4%
4.8%
6
Cell Reports
1338 papers in training set
Top 12%
4.3%
7
Protein & Cell
25 papers in training set
Top 0.6%
3.6%
8
eLife
5422 papers in training set
Top 27%
3.5%
50% of probability mass above
9
Cell Discovery
54 papers in training set
Top 1%
3.5%
10
Genome Medicine
154 papers in training set
Top 2%
3.2%
11
Science Advances
1098 papers in training set
Top 10%
2.7%
12
Cell Host & Microbe
113 papers in training set
Top 3%
1.9%
13
Nature
575 papers in training set
Top 11%
1.7%
14
Nature Biotechnology
147 papers in training set
Top 5%
1.6%
15
Immunity
58 papers in training set
Top 3%
1.5%
16
iScience
1063 papers in training set
Top 18%
1.5%
17
Journal of Clinical Investigation
164 papers in training set
Top 4%
1.5%
18
Cancer Discovery
61 papers in training set
Top 1%
1.3%
19
Science
429 papers in training set
Top 17%
1.2%
20
Cell Metabolism
49 papers in training set
Top 2%
1.2%
21
mBio
750 papers in training set
Top 9%
1.1%
22
eBioMedicine
130 papers in training set
Top 3%
0.9%
23
Nature Metabolism
56 papers in training set
Top 2%
0.9%
24
Clinical Infectious Diseases
231 papers in training set
Top 4%
0.8%
25
Microbiome
139 papers in training set
Top 3%
0.7%
26
Science Translational Medicine
111 papers in training set
Top 6%
0.7%
27
Molecular Cell
308 papers in training set
Top 10%
0.7%
28
Cell Reports Methods
141 papers in training set
Top 5%
0.7%
29
Nature Biomedical Engineering
42 papers in training set
Top 2%
0.7%
30
Nature Microbiology
133 papers in training set
Top 5%
0.7%